MICHAEL SPEER to Respiratory Syncytial Virus Infections
This is a "connection" page, showing publications MICHAEL SPEER has written about Respiratory Syncytial Virus Infections.
Connection Strength
0.225
-
Use of Palivizumab for prevention of hospitalization as a result of respiratory syncytial virus in infants with cystic fibrosis. Pediatr Infect Dis J. 2008 Jun; 27(6):559-61.
Score: 0.225
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.